Literature DB >> 14736714

Acute nontraumatic hemoabdomen in the dog: a retrospective analysis of 39 cases (1987-2001).

Jason Pintar1, Edward B Breitschwerdt, Elizabeth M Hardie, Kathy A Spaulding.   

Abstract

The medical records of 39 dogs with acute nontraumatic hemoabdomen were identified and reviewed. Anemia and hypoalbuminemia were identified in 36/37 (97%) and 25/33 (76%) dogs, respectively. Coagulopathies were identified in 26/31 (84%) dogs. When a definitive diagnosis was obtained, malignant neoplasia was diagnosed most frequently and occurred in 24/30 (80%) dogs. Hemangiosarcoma accounted for 21/30 (70%) diagnoses. Sixteen dogs underwent exploratory laparotomy, of which seven (44%) survived the perioperative period. Of the dogs that did not undergo surgery, 9/23 (39%) survived to be discharged from the hospital.

Entities:  

Mesh：

Year:  2003        PMID： 14736714     DOI： 10.5326/0390518

Source DB:  PubMed          Journal:  J Am Anim Hosp Assoc        ISSN： 0587-2871            Impact factor:   1.023


  11 in total

1.  Hemoabdomen secondary to high grade lymphoma.

Authors:  Carolina Azevedo; Stephanie Schleis Lindley; Annette Smith; Kellye Joiner; Peter Christopherson
Journal:  Can Vet J       Date:  2017-07       Impact factor: 1.008

2.  Outcome and prognostic factors for dogs with a histological diagnosis of splenic hematoma following splenectomy: 35 cases (2001-2013).

Authors:  Steve G Patten; Sarah E Boston; Gabrielle J Monteith
Journal:  Can Vet J       Date:  2016-08       Impact factor: 1.008

3.  Partial splenectomy for incidentally detected non-ruptured splenic lesions in dogs: 18 cases (2004-2018).

Authors:  Kaustubh R Dongaonkar; Daniel Linden; Jacqueline R Davidson; Harry W Boothe; D Michael Tillson; Brad M Matz
Journal:  Can Vet J       Date:  2019-11       Impact factor: 1.008

4.  Development and validation of a multivariable model and online decision-support calculator to aid in preoperative discrimination of benign from malignant splenic masses in dogs.

Authors:  Kristine E Burgess; Lori Lyn Price; Ryan King; Manlik Kwong; Eliza Grant; Katherine A Olson; Jeremiah A Lyons; Nicholas A Robinson; Kristin M Wendelburg; John Berg
Journal:  J Am Vet Med Assoc       Date:  2021-06-15       Impact factor: 1.936

5.  A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.

Authors:  Janet A Grimes; Nripesh Prasad; Shawn Levy; Russell Cattley; Stephanie Lindley; Harry W Boothe; Ralph A Henderson; Bruce F Smith
Journal:  BMC Vet Res       Date:  2016-12-03       Impact factor: 2.741

6.  Histopathologic characteristics of biopsies from dogs undergoing surgery with concurrent gross splenic and hepatic masses: 125 cases (2012-2016).

Authors:  Fernando J Leyva; Catherine A Loughin; Curtis W Dewey; Dominic J Marino; Meredith Akerman; Martin L Lesser
Journal:  BMC Res Notes       Date:  2018-02-13

Review 7.  Review of oncological emergencies in small animal patients.

Authors:  Katrina L Tumielewicz; Danielle Hudak; Jennifer Kim; David W Hunley; Lisa A Murphy
Journal:  Vet Med Sci       Date:  2019-03-21

8.  Pre-operative Hemostatic Status in Dogs Undergoing Splenectomy for Splenic Masses.

Authors:  Jourdan B McPhetridge; Alex M Lynch; Cynthia R L Webster; Emily McCobb; A M de Laforcade; Therese E O'Toole
Journal:  Front Vet Sci       Date:  2022-04-25

9.  Retrospective evaluation of thrombocytopenia and tumor stage as prognostic indicators in dogs with splenic hemangiosarcoma.

Authors:  Alison R Masyr; Aaron K Rendahl; Amber L Winter; Antonella Borgatti; Jaime F Modiano
Journal:  J Am Vet Med Assoc       Date:  2021-03-15       Impact factor: 1.936

10.  Single agent polysaccharopeptide delays metastases and improves survival in naturally occurring hemangiosarcoma.

Authors:  Dorothy Cimino Brown; Jennifer Reetz
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-05       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.